Clinical Trials in New York

Showing 841-860 of 10,830 trials

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

NCT06932081

This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failure-related outcomes.

Adult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right Ventricle+5 more

Leiden University Medical Center400 participantsStarted Jan 2023

Baltimore, Maryland, United States • Grand Rapids, Michigan, United States • New York, New York, United States +8 more locations

RECRUITINGPHASE3< 1 mile

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

NCT07104383

This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight

Weight Loss

Viking Therapeutics, Inc.1,100 participantsStarted Jun 2025

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +131 more locations

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Find Trials by Condition in New York

Hospital for Special Surgery Shoulder Arthroplasty Cohort

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

The Effectiveness of a Preoperative Blood Pressure Screening Program to Identify Undiagnosed Hypertension in Ambulatory Surgery Patients

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Biventricular Remodeling in Transcatheter Tricuspid Valve Replacement - Acute Hemodynamic Instability Study

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

Observational Study of LUMRYZ in Narcolepsy

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial